Breaking News, Collaborations & Alliances

Orgenesis, U of California, Davis Partner for CGT Mobile Processing Units and Labs

Orgenesis will install and operate OMPULs, enabling their POCare service platform to manufacture therapeutics at hospitals.

Orgenesis Inc., a global biotech company working to unlock the full potential of cell and gene therapies (CGT) at the point of care, entered into an agreement with the University of California, Davis (UC Davis), to roll out Orgenesis’ mobile processing units and labs (OMPULs) at medical or academic institutions within the University of California system. The partnership sets out a staged approach through which Orgenesis will install and operate OMPULs, enabling their point-of-care (POCa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters